Clinical Trial: First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848334) titled 'First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults' on Aug. 07.

Brief Summary: This study will evaluate the safety and tolerability of OPF-110 in healthy adult participants.

Study Start Date: Aug. 12

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: OPF-110

OPF-110 is an investigational 20% lipid injectable emulsion containing fish oil and medium-chain triglycerides administered by intravenous infusion.

DRUG: SMOFLIPID

SMOFlipid is a marketed 20% lipid injectable emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil administered by intravenous i...